FIELD: medicine.
SUBSTANCE: compound contacts with 15-lipoxygenase and tested for activity for 15-lipoxygenase inhibition.
EFFECT: extended range of medical products for treatment of diseases associated with bone loss.
7 cl, 6 ex, 4 tbl, 9 dwg
Authors
Dates
2009-06-20—Published
2007-09-03—Filed